Stock Analiz

Beneficient BENF

Finance: Consumer Services · data as of November 13, 2026

$0.63Market cap $12M
Open the interactive analysis →

Beneficient (BENF) is a financial company listed in the US with a market value of about $12M. In the twelve months to June 30, 2026 it had revenue of -$14M and net income of -$9M, a net margin of 63.2%.

Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is financial health (3/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of -11%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 50% below the current price.

About Beneficient

Beneficient is listed in the US and classified in finance: consumer services. It was profitable in 1 of the last 6 years in our data. Its share count fell by 72% over three years (buybacks).

Score: 1.2 / 5

Value0/5
Future growth0/5
Track record1/5
Financial health3/5
Shareholder returns2/5

Checks passed

  • ROE above 15%
  • More cash than debt, or low debt to equity
  • Interest covered more than 5 times
  • Debt below 3 years of free cash flow
  • Share count down over 3 years (buybacks)
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E0.7
P/FCF—
P/S—
P/B—
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-267.9%
Shareholder yield0.0%
Intrinsic value vs. price−50%

Growth and quality

Revenue growth (1 yr)—
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)589.4%
ROIC (5-yr avg.)-10.5%
Profitable years (of last 10)1
Years paying a dividend—

Financials, last 6 years

Fiscal yearTTM202620252024202320212020
Revenue-$14M-$39M—-$99M-$105M$55M$140M
Net income-$9M-$87M$51M-$2.1B-$131M-$63M-$58M
Free cash flow-$32M-$39M-$39M-$60M-$97M-$61M-$57M
EPS (diluted)$-0.48$-4.60——$-1.94$-1.84$-1.27
Net margin63.2%223.5%—2123.3%124.9%-113.9%-41.4%
ROIC————-14.6%-6.5%-3.8%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 1 analysts is $9.00, 1332% above the current price; targets range from $9.00 to $9.00; the consensus rating is “Strong buy”; expected EPS is $-2.60 for the fiscal year ending March 31, 2027.

Frequently asked questions

Is Beneficient stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 50% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Beneficient pay a dividend?

Not currently.

Is Beneficient a good stock to buy?

We do not give buy or sell advice. Beneficient scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.